The impact of anti-CD20-based therapy on hypogammaglobulinemia in patients with follicular lymphoma. Fischer T, Ni A, Bantilan KS, Soumerai JD, et al. Leuk Lymphoma 2022 Feb 3:1-10. doi: 10.1080/10428194.2021.2010058.

Read + Share

Amedeo Smart

Independent Medical Education

Fischer T, Ni A, Bantilan KS, Soumerai JD, et al. The impact of anti-CD20-based therapy on hypogammaglobulinemia in patients with follicular lymphoma. Leuk Lymphoma 2022 Feb 3:1-10. doi: 10.1080/10428194.2021.2010058.
PMID: 35109746